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showednosignificantcorrelationbetweencentral line–daysand
rate of CLABSIs (P = .95, determined by the Pearson χ2 test).
Discussion | Burn ICUs have been plagued by higher rates of
nosocomial infectionsandassociatedcomplications thanother
ICUs,andCLABSIshavebeenan importantcontributor to those
rates.4 Since the implementation of a multidisciplinary and
multimodalCLABSIbundle customized toourBTICU,wehave
hadnoCLABSIs.We also have significantly reduced thenum-
ber of central line–days, likely owing to the daily assessment
of the need for central access, with a simultaneous increase
in the total number of patient-days andnodecrease in the fre-
quency of blood cultures. We did not collect data on ana-
tomic siteof catheter insertionbecauseour longstandingprac-
tice has been to optimize the catheter’s distance from burn
wound, and this did not change during the review period.5
Because of themultimodal nature of our intervention, we
are unable to isolate a singlemeasure that resulted in our zero
CLABSI ratesinceSeptember2013.OurCLABSIbundlehasbeen
successful for our center and can be used as a foundation for
other burn centers and ICUs to develop similar protocols. The
implementation of a multimodal, multidisciplinary CLABSI
bundle transformedaburn ICUthatwasperformingbetter than
nationalnorms forCLABSI rates toonewithazeroCLABSI rate.
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ASSOCIATIONOFVA SURGEONS
Analysis of Cases inWhich a Biopsy Specimen
Is Positive and an Excised Lesion Is Negative
for Nonmelanoma Skin Cancer
Nonmelanomaskincancers (NMSCs), including squamouscell
carcinoma (SCC) and basal cell carcinoma (BCC), are themost
common types of cancer with the fastest-growing treatment
costs in the United States.1 Standard treatment requires bi-
opsy for histologic confirmation, followedby excision.Often-
times, no residual carcinoma is detected, implying spontane-
ous clearance at rates reported to vary from 24% to 76%.2-5
These types of lesionshavebeen investigatedbyothers2-5 and
are not fully understood. Our study aims to determine the le-
sion andpatient characteristics thatwouldmost strongly pre-
dict a histologically negative result for an excised lesion after
a biopsy specimen had positive margins.
Methods | Our retrospective database study was approved by
the institutional reviewboardof theRichardL.RoudebushVet-
erans Affairs Medical Center in Indianapolis, Indiana; in-
formed consent was not obtained because the data were de-
identified. Our study was conducted using the International
Table 2. Central Line Data Before and After Intervention
Data
Before
(30 mo)
After
(18 mo) P Valuea
No. of blood cultures per 1000 central line–days, median (IQR) 56 (30-86) 79 (53-110) .08
No. of CLABSIs 11 0 <.001
No. of CLABSIs per 1000 central line–days, mean (SD) 1.2 (1.9) 0 (0) .02
No. of CLABSIs per 1000 patient-days, mean (SD) 2.2 (3.9) 0 (0) .01
No. of patient-days, median (IQR) 335 (287-346) 390 (343-426) .002
No of central line–days, median (IQR) 168 (142-207) 132 (109-164) .03
No of central line–days per 1000 patient-days, median (IQR) 0.57 (0.46-0.65) 0.34 (0.30-0.44) .001
Abbreviations: CLABSIs, central line
associated bloodstream infections;
IQR, interquartile range.
a Determined by use of the t test or
the Fisher exact test.
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Classification ofDiseases, NinthRevision codes forNMSCs and
theCurrent Procedural Terminology codes for bothbiopsy and
excision of lesions treated at the Richard L. Roudebush Vet-
erans Affairs Medical Center during the period from 2003 to
2013. Data were collected for primary NMSCs that had a posi-
tive-margin biopsy followed by lesion excision. Lesions that
underwent concurrent dermatologic treatment were ex-
cluded from our study. Patients with more than 20 lesions in
a lifetime were also excluded. Bivariate analysis was per-
formed to identify the parameters that significantly contrib-
uted to the negative results regarding the excised lesions.
Analysis was performed using SAS (SAS Institute Inc). P = .05
was considered statistically significant.
Results | The inclusion and exclusion criteria described in the
Methods section yielded a total of 1867 lesions from 1299 pa-
tients who were mostly white (92%), male (99%), and be-
tween the ages of 50 and90years (97%) (mean age, 72 years).
Therateofexcised lesions that testednegativewas58%incases
of SCC and 23% in cases of BCC. Parameters significantly as-
sociatedwithnegative results after excisionwere type of can-
cer (SCC or BCC), histologic appearance of scar or ulcer after
excision, clinical appearanceof scar after biopsybutbefore ex-
cision, prebiopsy ulceration, type of biopsy (punch or shave),
andsimplifiedanatomicsite (headandneckor trunkand limb).
TheirPvaluesandoddsratiosare listed in theTable.Oddsratios
for lesions subdivided by SCC and BCC are also listed. Clini-
cally important associations included thehistologic findingof
a scar after excision, clinical appearance of a scar after biopsy
but before excision, histologic ulceration on the excised le-
sion, clinical or histologic ulceration on the biopsy specimen,
and location in the head and neck.
Discussion |Our study includeddata collected fromavery large
Veterans Affairs Medical Center data set; variables not likely
to be importantwith regard to excised lesions thatwerenega-
tive for residual cancer include age, diabetes, immunosup-
pression, Vietnam service, Agent Orange exposure, nicotine
use, and number of days between biopsy and excision. The
mostsignificantpre-excisional factorwasNMSCtype, forwhich
casesofSCChadahigher rateofexcised lesions thatwerenega-
tive than did cases of BCC. The literature suggests that the bi-
opsy-inducedwound-healingprocess is amajor causeof these
negative findings after excision4-6 and is consistent with the
results of our study. The clinical appearance of just a scarwas
predictive, with odds ratios for a negative finding after exci-
sion of 4.6 for cases of SCC and 1.9 for cases of BCC. Histori-
cally, themean (SD) recurrence rate for surgical excisionwith
a 4-mmmargin has been reported at 1.6% (1.8%).7
The 2 major limitations of our study are its veteran popu-
lation (mostly white male patients), which limits generaliza-
tion to all populations, and our inability to verify total lack of
NMSCinexcisionspecimensviapathology.Althoughlesionsare
“breadloafed,” not every part of the section is viewed. A logis-
tic regression analysiswould help identify additional relation-
ships, aswell as confounders, among the variables andmaybe
useful in creating a prediction model for negative findings af-
ter excision that can be used tomake cost-cutting decisions in
the clinic. Such amodel would allow patients with a high like-
lihoodofanegativefindingafterexcisionandwithalimitedlifes-
pantobetreatedconservativelybecausethechanceoftheNMSC
causing significantmorbiditywouldbeminimal. Currently, no
long-termoutcomedata exist, and so further studies are being
conducted. Patients with a high probability of negative find-
ingsafterexcisionarerandomlyassignedto1of2different treat-
Table. Data on Spontaneous Clearance of Residual Carcinoma by Histology in Biopsied NMSCs for Studied Variables Subdivided
by SCC and BCC in Bivariate Analysisa
Parameter
Overall SCC BCC
OR P Value OR P Value OR P Value
Cancer type (SCC vs BCC) 3.4352 <.001
Scar in excision pathology report 10.8932 <.001 13.9621 <.001 8.1125 <.001
Ulcer in excision pathology report 0.5054 <.001 0.3385 <.001 0.5958 .05
Scar in pre-excision clinic report 2.2917 <.001 4.6142 <.001 1.8621 .003
Location (head/neck vs trunk/limb) 0.5498 <.001 0.4986 <.001 … .98
Ulcer in biopsy clinic/pathology report 0.6004 <.001 0.5555 .002 … .34
Original size of lesion 0.9460 <.001 0.9390 <.001 0.8850 <.001
Biopsy specimen size 1.0410 <.001 … .30 … .10
Biopsy type (punch vs shave) 0.5257 .01 0.3503 .01 … .18
Size of excised lesion 0.9900 .01 0.9790 .003 0.9780 .004
No. of days between biopsy and excision 0.9980 .05 … .90 … .07
Nicotine use 0.9960 .05 … .06 0.9920 .03
Immunosuppression … .26 … .49 … .84
Vietnam service … .34 … .56 … .67
Age … .45 … .13 … .53
Diabetes … .80 … .85 … .65
Agent Orange exposure … .82 … .434 … .44
Abbreviations: BCC, basal cell carcinoma; NMSCs, nonmelanoma skin cancers; OR, odds ratio; SCC, squamous cell carcinoma.
a Odds ratios were not provided for variables that were not statistically significant to P = .05 (and some variables lost significance when analyzed within the
subcategory of cancer type SCC or BCC).
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mentgroups: conservative therapyorsurgical excision.Thepa-
tientswould thenbecloselymonitoredyearly for recurrence to
determine theutilityofpredictionandof conservative therapy.
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Barriers to Participation in Preoperative
Risk-Reduction Programs Prior to Ventral Hernia
Repair: AnAssessment of Underserved Patients
at a Safety-Net Hospital
Nearly 80% of patients presenting with a ventral hernia
have modifiable risk factors such as obesity, poor fitness,
smoking, and poorly controlled diabetes mellitus.1 Preop-
erative risk-reduction programs have been shown to be
effective in behavior modification. However, generalizabil-
ity of these outcomes to underserved patients may be hin-
dered by unrecognized barriers.2 The aim of this study was
to identify patient-reported barriers to successful imple-
mentation of a preoperative risk-reduction program at a
safety-net hospital.
Methods |Thiswas a prospective, qualitative study of patients
evaluated at an outpatient hernia clinic at LyndonB. Johnson
General Hospital, Houston, Texas. The study was initiated
concurrently with the development of a preoperative risk-
reduction program.3 Interviews were conducted to investi-
gate patient perspectives of their current health status, de-
sire for risk modification, and barriers to participation.
Sampling was continued until thematic saturation was
achieved. Responses were correlated with clinical data. Na-
tional guidelineswereused todefine standards forobesity and
quality of diabetic control.4
This studywasapprovedby the institutional reviewboard
of the Harris Health System (HSC-MS-14-1025). Oral consent
was obtained from all study participants.
Table 1. Comorbidities of 43 Patients
Variable
No. (%)
Self-reported Actual Incorrect Self-assessmenta
Overweight 33 (76.7) 40 (93.0) 7 (16.3)
BMI, 25-29.9 NA 8 (18.6) 3 (7.0)
BMI ≥30 NA 32 (74.4) 4 (9.3)
Current smoker 8 (18.6) NA NA
Poor fitness 16 (38.1) 10 Repetitions (9-16)b 6 (14.0)
Diabetes or prediabetes 14 (32.6) 23 (53.5) 9 (20.9)
HbA1C , 5.7%-6.4%c 5 (11.6) 14 (32.6) 9 (20.9)
HbA1C >6.5%c 9 (20.9) 9 (20.9) 0 (0)
Abbreviations: BMI, bodymass index (calculated asweight in kilograms divided
by height inmeters squared); HbA1c, glycated hemoglobin; NA, not applicable.
SI conversion factor: To convert HbA1C to proportion of total hemoglobin,
multiply by 0.01.
a All incorrect self-assessments were underestimates (ie, not overweight, no
diabetes, or fit).
bMedian repetitions (range) in the sit and stand test. The sit and stand test is a
standardized test of fitness and endorsed by the Centers for Disease Control
and Prevention. Theminimum expected threshold is 14 repetitions for men
and 12 repetitions for women older than 60 years. Standards have not been
established for those younger than 60 years.5
c Definitions of prediabetes (5.7%-6.4%) and diabetes (6.5%).
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